SEVILLE, Spain — Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to 80% of cases, according to the literature.
It is often difficult to treat, requires a higher than average number of injections and can often lead to retinal pigment epithelial (RPE) tears. Are the new-generation anti-VEGF agents more specifically beneficial for pigment epithelial detachment (PED)? Two specialists at the Congress on Controversies in Ophthalmology shared their views.
Post hoc analyses of clinical trials and real-world studies indicate that